Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City. Sepulveda J, Westblade LF, Whittier S, Satlin MJ, Greendyke WG, Aaron JG, Zucker J, Dietz D, Sobieszczyk M, Choi JJ et al.. 2020. Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City.. J Clin Microbiol. 58(8) Read more about Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City. Google Scholar
Bacterial Coinfections in Coronavirus Disease 2019. Westblade LF, Simon MS, Satlin MJ. 2021. Bacterial Coinfections in Coronavirus Disease 2019.. Trends Microbiol. 29(10):930-941. Read more about Bacterial Coinfections in Coronavirus Disease 2019. Google Scholar
Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study. Hansen G, Marino J, Wang Z-X, Beavis KG, Rodrigo J, Labog K, Westblade LF, Jin R, Love N, Ding K et al.. 2021. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.. J Clin Microbiol. 59(2) Read more about Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study. Google Scholar
Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease. Yantiss RK, Qin L, He B, Crawford CV, Seshan S, Patel S, Wahid N, Jessurun J. 2021. Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.. Am J Surg Pathol. Read more about Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease. Google Scholar
Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020. Bushman D, Alroy KA, Greene SK, Keating P, Wahnich A, Weiss D, Pathela P, Harrison C, Rakeman J, Langley G et al.. 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.. MMWR Morb Mortal Wkly Rep. 69(28):918-922. Read more about Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020. Google Scholar
SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19. Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, Goyal P, Sepulveda JL, Zhang L, George G et al.. 2020. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.. Cancer Cell. 38(5):661-671.e2. Read more about SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19. Google Scholar
Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE et al.. 2021. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.. J Clin Invest. 131(7) Read more about Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. Google Scholar
Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. Satlin MJ, Goyal P, Magleby R, Maldarelli GA, Pham K, Kondo M, Schenck EJ, Rennert H, Westblade LF, Choi JJ et al.. 2020. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.. PLoS One. 15(7):e0236778. Read more about Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease. Google Scholar
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Alpert T, Brito AF, Lasek-Nesselquist E, Rothman J, Valesano AL, MacKay MJ, Petrone ME, Breban MI, Watkins AE, Vogels CBF et al.. 2021. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.. Cell. 184(10):2595-2604.e13. Read more about Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Google Scholar
Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs. Craney A, Petrik D, Suhku A, Qiu Y, Racine-Brzostek S, Rennert H, Piscatelli H, Rathnaiah G, Hangman A, Carrie M et al.. 2021. Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.. Microbiol Spectr. 9(1):e0008321. Read more about Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs. Google Scholar
